Top Markets
Coin of the day
Monterey Bio Acquisition Corporation Monterey Bio Acquisition Corporation

Monterey Bio Acquisition Corporation

MTRY
株式のランク #19499
Monterey Bio Acquisition Corporation currently lacks substantial operational... Monterey Bio Acquisition Corporation currently lacks substantial operational activities. Its primary goal is to achieve a business combination—including but not limited to mergers, capital stock exchanges, asset acquisitions, or reorganizations—with companies in the biotechnology industry. The firm, established in 2020, was formerly known as Chardan FinTech Acquisition Corp. and rebranded to Monterey Bio Acquisition Corporation in April 2021. It is headquartered in New York, New York.
株価
$11.14
最終同期: 2023-11-28
時価総額
$160.14M
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 Monterey Bio Acquisition Corporation (MTRY)

カテゴリー

Monterey Bio Acquisition Corporation(MTRY)の利益
2026 時点の利益 TTM: 0
Monterey Bio Acquisition Corporation の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Monterey Bio Acquisition Corporation の利益の推移(2026 〜 2026)
各年末の利益
利益 変化
提供された日付のデータは十分ではありません。